| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,962 |
11,250 |
$569K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,606 |
7,180 |
$244K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,323 |
3,028 |
$226K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,563 |
2,457 |
$140K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,188 |
2,075 |
$113K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
939 |
898 |
$49K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
330 |
280 |
$47K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
464 |
448 |
$27K |
| 92583 |
|
1,166 |
1,135 |
$27K |
| 92552 |
|
1,375 |
1,323 |
$15K |
| 99177 |
|
1,401 |
1,349 |
$13K |
| D1208 |
Topical application of fluoride, excluding varnish |
818 |
811 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
827 |
770 |
$10K |
| 96127 |
|
1,467 |
1,327 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
481 |
233 |
$6K |
| 90670 |
|
1,539 |
1,458 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
206 |
193 |
$5K |
| 90698 |
|
986 |
940 |
$3K |
| 90686 |
|
1,718 |
1,689 |
$2K |
| 90671 |
|
28 |
27 |
$2K |
| 90716 |
|
206 |
201 |
$2K |
| 90633 |
|
416 |
403 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
56 |
53 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
202 |
199 |
$1K |
| 90707 |
|
207 |
202 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
28 |
28 |
$875.92 |
| 90680 |
|
934 |
880 |
$790.25 |
| 90651 |
|
40 |
40 |
$777.30 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$536.93 |
| 90744 |
|
417 |
394 |
$417.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
102 |
102 |
$379.66 |
| 90620 |
|
12 |
12 |
$237.20 |
| 90734 |
|
26 |
26 |
$231.38 |
| 90674 |
|
294 |
257 |
$67.78 |
| 90696 |
|
20 |
20 |
$40.00 |
| 90681 |
|
26 |
26 |
$20.00 |
| 1036F |
|
403 |
402 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
866 |
806 |
$0.00 |
| 90660 |
|
16 |
16 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
348 |
346 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
222 |
201 |
$0.00 |
| 90656 |
|
64 |
60 |
$0.00 |
| 90697 |
|
15 |
15 |
$0.00 |
| 90723 |
|
13 |
13 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
122 |
105 |
$0.00 |
| 90677 |
|
15 |
15 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
7,428 |
6,210 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
2,645 |
2,584 |
$0.00 |
| 90461 |
|
36 |
36 |
$0.00 |
| 90700 |
|
39 |
39 |
$0.00 |
| 90648 |
|
113 |
105 |
$0.00 |
| 99072 |
|
566 |
499 |
$0.00 |
| 90672 |
|
114 |
106 |
$0.00 |